HIV Vaccine Research a Field Apart From Classic Vaccinology

HIV vaccine research is diverging from classic vaccinology and its focus on the adaptive immune response, to a field of its own. There has been a shift from protecting against infection to changing the nature of the infection, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), in Bethesda, Maryland, said in his keynote address here at the National Foundation for Infectious Diseases 13th Annual Conference on Vaccine Research.